Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moupali Das

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
AIDS and Behavior|May 9, 2015
Self-Reported HIV and HCV Screening Rates and Serostatus Among Substance Abuse Treatment PatientsDiana Hernández, Daniel J Feaster, Lauren Gooden, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2016
Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 StudyFrank A Post, Pablo Tebas, Amanda Clarke, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 13, 2016
Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B-Coinfected AdultsJoel Gallant, Jason Brunetta, Gordon Crofoot, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 16, 2013
Linkage to HIV care in San Francisco: implications of measure selectionMoupali Das, Katerina A Christopoulos, Dara Geckeler, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 11, 2013
Dose-response associations between number and frequency of substance use and high-risk sexual behaviors among HIV-negative substance-using men who have sex with men (SUMSM) in San FranciscoGlenn-Milo Santos, Phillip O Coffin, Moupali Das, et al.
AIDS and Behavior|February 11, 2014
Adapted personalized cognitive counseling for episodic substance-using men who have sex with men: a randomized controlled trialPhillip O Coffin, Glenn-Milo Santos, Grant Colfax, et al.
Drug and Alcohol Dependence|March 20, 2014
Substance use and drinking outcomes in Personalized Cognitive Counseling randomized trial for episodic substance-using men who have sex with menGlenn-Milo Santos, Phillip O Coffin, Eric Vittinghoff, et al.
The Lancet. HIV|October 4, 2019
Bone mineral density in virologically suppressed people aged 60 years or older with HIV-1 switching from a regimen containing tenofovir disoproxil fumarate to an elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide single-tablet regimen: a multicentre, open-label, phase 3b, randomised trialFranco Maggiolo, Giuliano Rizzardini, François Raffi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 19, 2016
A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected AdultsGregory D Huhn, Pablo Tebas, Joel Gallant, et al.
The Journal of Infectious Diseases|November 16, 2023
HIV Prevention Among Men Who Have Sex With Men: Tenofovir Alafenamide Combination Preexposure Prophylaxis Versus PlaceboPaul N Zivich, Stephen R Cole, Jessie K Edwards, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
AIDS and Behavior|May 9, 2015
Self-Reported HIV and HCV Screening Rates and Serostatus Among Substance Abuse Treatment PatientsDiana Hernández, Daniel J Feaster, Lauren Gooden, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2016
Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 StudyFrank A Post, Pablo Tebas, Amanda Clarke, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 13, 2016
Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B-Coinfected AdultsJoel Gallant, Jason Brunetta, Gordon Crofoot, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 16, 2013
Linkage to HIV care in San Francisco: implications of measure selectionMoupali Das, Katerina A Christopoulos, Dara Geckeler, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 11, 2013
Dose-response associations between number and frequency of substance use and high-risk sexual behaviors among HIV-negative substance-using men who have sex with men (SUMSM) in San FranciscoGlenn-Milo Santos, Phillip O Coffin, Moupali Das, et al.
AIDS and Behavior|February 11, 2014
Adapted personalized cognitive counseling for episodic substance-using men who have sex with men: a randomized controlled trialPhillip O Coffin, Glenn-Milo Santos, Grant Colfax, et al.
Drug and Alcohol Dependence|March 20, 2014
Substance use and drinking outcomes in Personalized Cognitive Counseling randomized trial for episodic substance-using men who have sex with menGlenn-Milo Santos, Phillip O Coffin, Eric Vittinghoff, et al.
The Lancet. HIV|October 4, 2019
Bone mineral density in virologically suppressed people aged 60 years or older with HIV-1 switching from a regimen containing tenofovir disoproxil fumarate to an elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide single-tablet regimen: a multicentre, open-label, phase 3b, randomised trialFranco Maggiolo, Giuliano Rizzardini, François Raffi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 19, 2016
A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected AdultsGregory D Huhn, Pablo Tebas, Joel Gallant, et al.
The Journal of Infectious Diseases|November 16, 2023
HIV Prevention Among Men Who Have Sex With Men: Tenofovir Alafenamide Combination Preexposure Prophylaxis Versus PlaceboPaul N Zivich, Stephen R Cole, Jessie K Edwards, et al.
Pageof 7